Previously disclosed buy-backs 0 n.a. n.a.

Book-to-bill above 1 and sales organic growth around 5% aEBIT margin around 6.5% Free Cash Flow within the range €300 million to €500 million 13 November 2024 – In the first half of fiscal year ...

on November 14, 2024 at 6:00 pm Dubai time / 3:00 pm Oslo time. Dial-in details for the call are included in the press release posted on November 6, 2024 and on page 2 of this release.

556,500 shares in the Company, by way of donation/gift of 100% of the share capital in Sea Shell Enterprises Limited to members of his family. Following the transactions, Themistoklis Alafouzos will ...

Reference is made to the notice of a letter of award for the provision of a ...

- Svein Oskar Stoknes has acquired 1,400 shares. Mr. Stoknes' total shareholding in Aker after the acquisition will be 11,400 shares. - Lene Landøy has acquired 1,000 shares. Mrs. Landøy's total ...

3:00 pm Oslo time. Dial-in details for the call are included in the press release posted on November 6, 2024 and on page 3 of this release.

Netherlands and the planned Gismarvik CO2 hub in Norway. Park is intended to play a key role as the import terminal and injection hub for permanent sequestration of the CO2 on the Norwegian ...

issue of between 107,382,966 to 150,000,000 new shares in the Company, (the "Rights Issue"), of which an underwriting consortium (jointly the "Underwriters") agreed to underwrite subscription of new ...

Crossject successfully completes a new U.S. summative human factors study to assess the usability of ZENEO® Midazolam, soon to be commercialized globally as ZEPIZURE®, under simulated chemical attack ...

of new shares in the Company (the "Offer Shares"). The share capital increase related to issuance of Offer Shares in the Private Placement has today been registered with the Norwegian Register of ...

315,000,000 bonds 2024/2028 ISIN: NO0013220285 on Nordic ABM as of today. Attached is the Bond Terms, as well as the Admission Document and Loan Description prepared in connection with the listing.